A rapid and highly sensitive method to determine drugs in human serum by liquid chromatography/atmospheric pressure ionization mass spectrometry (LC/API-MS) is reported. This method has wide applicability and high sensitivity, with detection limits ranging from ng/ml to µg/ml. Experimental results demonstrate that the LC/API-MS is very promising for determination of drugs in human serum.
In general, serum levels of drugs correlate well with clinical responses. Appropriate levels are consistent with desirable clinical responses, whereas excess serum levels are often associated with toxic effects. Thus the monitoring of serum drug levels is very important in treating patients. Clinical fields require a rapid, highly sensitive method to determine drugs in human serum.l-3
For this purpose, liquid chromatography/ ultraviolet detection (LC/ UVD)4'5, liquid chromatography/electrochemical detection (LC/ ECD)6'', fluorescence immunoassay (FIA)8, enzyme immunoassay (EIA)9 and other methods are widely used. However, LC/ UVD and LC/ ECD require time-consuming pretreatment to eliminate interferences due to serum components for the separation of drugs. FIA and EIA are simpler to perform. However, they do not work well with small amounts of serum due to their low sensitivities.8 '9 The authors have previously developed a liquid chromatography/ atmospheric pressure ionization mass spectrometry (LC/ API-MS).1o-13 This LC/API-MS has wide applicability and high sensitivity."' 3 Therefore, the LC/ API-MS is expected to determine various kinds of drugs in human serum with high sensitivity. However, analytical conditions and detection limits of drugs are not clear because no drug analyses by the LC/API-MS have been reported. This paper reports the detection limits of drugs by the LC/ API-MS to prove that it is very promising for determination of drugs in human serum. Theophylline (TP), a drug for asthma, is determined by the LC/API-MS as one example.
Experimental Apparatus A Hitachi liquid chromatograph / atmospheric pres-sure ionization mass spectrometer equipped with a column (Hitachi gel #3056 (ODS), 4 mmX 150 mm) was used to analyze drugs.'o-'2 A schematic diagram of the interface and the ion source is shown in Fig. 1 . In this system, LC effluents were vaporized by an interface composed of a nebulizer and a vaporizer. Vaporized sample molecules were ionized by a corona discharge, followed by ion-molecule reactions. The ions produced were introduced into a mass analyzing region through two apertures.
Reagents
Nineteen drugs requiring therapeutic monitoring were selected to investigate LC/ API-MS sensitivity. Gentamycin Cl, kanamycin A, and thiolutin were kindly supplied by the Institute of Microbial Chemistry (Tokyo, Japan). Other drugs were purchased from Kanto Chemicals (Tokyo, Japan). Patient sera containing TP were kindly supplied by Special Reference Laboratories (SRL) (Tokyo, Japan).
Operation
In the sensitivity experiments, drugs were detected using water/ methanol (50/ 50) at a flow rate of 1.2 ml/ min without the column. Although a higher flow rate was preferable to shorten analysis time, a flow rate of over 1.3 ml/ min decreased LC/ API-MS sensitivity. Ten microliters of samples were injected into the chromatograph.
Serum TP was determined as follows. A serum sample (20 µl) was deproteinized by adding 40 µl of methanol containing theobromine (TB) (2 µg/ ml). After centrifugation at 20000 rpm for 30 s, 10 µl of the supernatant was injected into the liquid chromatograph. Serum TP was determined by measuring peak area ratios of TP to TB. Total analysis time for determination was about 5 min.
Results and Discussion
Analyses of drugs by LC/API-MS The mass numbers of monitoring ions, detection limits (S/ N=5) and the effective drug concentrations in serum without toxic effects14 are shown in Table 1 . In the LC/ API-MS, protonated quasi-molecular ions, which are very useful for identifying drugs, are observed. This result demonstrates the wide applicability of the LC/ API-MS.
Furthermore, the LC/ API-MS can detect drug concentrations ranging from ng/ ml to µg/ ml. These detection limits are less than the effective drug concentrations. These results prove that the LC/API-MS is applicable to determination of drugs.
Determination of theophylline (TP) in patient serum
Selection of internal standards and mobile phase composition is important for drug analysis. As an internal standard, TB was selected over 8-chlorotheophylline, sulfamonomethoxine, 7-(2-hydroxyethyl)-theophylline and caffeine (CF) because only TB was eluted earlier than TP from the column. This is effective to shorten analysis time. A selected ion detection (SID) method was used to monitor the quasi-molecular ions of TP and TB (m/z=181).
Mobile phase composition greatly affects LC resolution. Therefore, the authors carefully investigated a mobile phase composition in which TP and TB could be separated perfectly in a short time. The composition of a water/ methanol mixture, which is a typical mobile phase for Hitachi gel #3056 (ODS), was varied. TP and TB could be separated within 3 min when water/ methanol (70/30) was used as the mobile phase at a flow rate of 1.2 ml/ min. Therefore, in subsequent experiments on serum TP determination, the mobile phase was maintained as water/ methanol (70/30). This establishment of the analytical condition in the LC/API-MS was very easy compared with that of LC/ UVD or LC/ ECD because separation of TP and other components in serum must not be considered in the LC/API-MS.
Determination of TP in patient serum was carried out using a calibration curve. Chromatograms obtained by ultraviolet detector (~=250 nm) of a control serum containing no drugs and a control serum containing 2 µg/ ml each of TP, TB and CF, and mass chromatograms obtained by multiple ion detection (MID) mode for the same serum are shown in Fig. 2 . TP, TB and CF were difficult to be detected with an ultraviolet detector due to interfering serum components.
In contrast, the LC/API-MS detected TP, TB and CF with satisfactory sensitivity.
A calibration curve was made by measuring peak area ratios of various concentrations of TP to TB, as shown in Fig. 3 . Good linearity was observed in the range of 1 to 40 µg/ ml.
The within-run and between-run reproducibilities in detecting TP for 10 µg/ ml were 4.8% and 5.6%, and those for 20 µg/ml were 4.1% and 5.8%, respectively. Such stability is good enough to determine serum TP as a routine work.
The TP in patient serum was determined and compared with the result by EIA method, as shown in Fig. 4 (y=1.lx+0 .38, y: EIA, x: LC/API-MS) (r=0.98, n=10). The results obtained by LC/API-MS and EIA methods correlated well, which proves that the determination by the LC/API-MS is very reliable.
In the analysis of serum, the sample amount used should be reduced as small as possible. The serum amount is 20 -50 µl in the conventional methods. In this experiment, 10 µl serum was used. However, it can be reduced to 0.1.tl for determination of serum TP ranging from 1 to 50 µg/ ml, judging from the LC/ API-MS sensitivity listed on Table 1 .
The results mentioned above show that the LC/ API-MS is very promising for a rapid, highly sensitive method to determine drugs in human serum.
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